logo

FBRX

Forte Biosciences·NASDAQ
--
--(--)
--
--(--)

FBRX fundamentals

Forte Biosciences (FBRX) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.96 (YoY +85.78%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.96
+85.78%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 13, 2025
Meeting link.
EPS
Q3,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q1,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-161.25-238-11.25-9-13.5-4.25-5.25-4.5-6-8-10.5-6.50-4-6.75-4.543.12-1.37-0.96
Forecast
-165-4.5-11.0833-11.5919-8.875-1.75-4.25-4.25-3.75-4-14.25-7-3.5-3.9375-6.3333-1.9925-0.95-1.1075
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+2.27%
-5188.89%
-1.50%
+22.36%
-52.11%
0.00%
0.00%
-23.53%
-20.00%
-50.00%
0.00%
0.00%
+54.39%
+100.00%
-14.29%
-71.43%
+28.32%
+256.59%
-44.21%
+13.32%
Revenue
Q3,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q1,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--------------------000----00------000000000
Forecast
------------------0000000000----00000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call